Dermatology · Palo Alto, CA
NPI
1215121280
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
900 Blake Wilbur Dr
Palo Alto, CA, 94304
Phone (650) 736-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
4,109 services
Medicare patients, 2024
1,019
Average age 74
Drug cost, 2024
$1.2M
3,156 prescriptions
Company payments, 2025
$3,150
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Navi was code 17003 (destruction skin lesion), 1,298 times for 182 patients. In total Daniel Navi billed 4,109 services in 47 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,298 | 182 | $5.60 | $7,269 |
| 99213 Office E&M - Established | Office | 804 | 547 | $65.81 | $53K |
| 17000 Destruction Skin Lesion | Office | 351 | 240 | $43.60 | $15K |
| 17110 Destruction Skin Lesion | Office | 336 | 234 | $89.15 | $30K |
| 99203 Office E&M - New | Office | 247 | 247 | $75.17 | $19K |
| 99212 Office E&M - Established | Office | 162 | 142 | $44.39 | $7,191 |
| 11102 Skin Biopsy | Office | 162 | 150 | $76.63 | $12K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 151 | 42 | $0.66 | $99.39 |
| 99214 Office E&M - Established | Office | 100 | 68 | $97.41 | $9,741 |
| 17004 Destruction Skin Lesion | Office | 92 | 54 | $132.37 | $12K |
| 99202 Office E&M - New | Office | 73 | 73 | $48.03 | $3,507 |
| 96372 Injection Administration | Office | 67 | 27 | $10.88 | $729 |
| 11900 Skin | Office | 37 | 28 | $39.71 | $1,469 |
| 99204 Office E&M - New | Office | 30 | 30 | $123.19 | $3,696 |
| 17111 Destruction Skin Lesion | Office | 24 | 17 | $90.34 | $2,168 |
By year: 2022 $202K for 3,589 services; 2023 $183K for 3,799 services; 2024 $193K for 4,109 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 13 | 12 | $5.76 | $74.83 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Navi prescribed most often to Medicare patients was Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc), with 457 prescriptions and refills. In total Daniel Navi wrote 3,156 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 457 | 486 | 188 | $34K |
| Ketoconazole Generic | 333 | 342 | 84 | $4,049 |
| Triamcinolone Acetonide Generic | 318 | 343 | 186 | $2,644 |
| Clobetasol Propionate Generic | 299 | 301 | 105 | $14K |
| Hydrocortisone Generic | 207 | 208 | 101 | $2,664 |
| Fluocinonide Generic | 191 | 198 | 72 | $8,389 |
| Finasteride Generic | 155 | 243 | 34 | $966 |
| Clindamycin Phosphate Generic | 135 | 138 | 51 | $4,890 |
| Hydroxyzine Hcl Generic | 87 | 107 | 35 | $1,021 |
| Doxycycline Hyclate Generic | 78 | 84 | 47 | $1,507 |
| Metronidazole Generic | 77 | 77 | 30 | $2,454 |
| Minoxidil Generic | 75 | 132 | 19 | $564 |
| Mometasone Furoate Generic | 70 | 75 | 27 | $1,039 |
| Dupixent Pen Dupilumab | 59 | 63 | Under 11 | $218K |
| Terbinafine Hcl Generic | 48 | 48 | 28 | $296 |
Brand drugs: 308 claims; generic drugs: 2,848 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Navi $3,150 ($3,150 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $385.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $385 |
| Incyte Corporation INCY | 18 | $324 |
| LEO Pharma Inc. | 15 | $300 |
| Galderma Laboratories, L.P. GALD.SW | 21 | $293 |
| Janssen Biotech, Inc. JNJ | 12 | $249 |
| Genzyme Corporation SNY | 6 | $227 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $215 |
| Amgen Inc. AMGN | 10 | $213 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $187 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $169 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.